Vivalink Medical, a Santa Clara, CA-based remote patient monitoring services company, received an investment from Niterra, through the CVC fund jointly operated with Pegasus Tech Ventures.
The amount of the deal was not disclosed.
The copmany intends to use the funds to expand operations and development efforts to support technology detecting and assessing Cardiology, Oncology, Neurology, and Hypertension conditions. The investment enhances healthcare with clinical grade physiology metrics powered by wearable sensors, network data services, algorithms, and clinician portals
Led by Jiang Li, Founder and CEO, Vivalink Vivalink provides a biometric platform that accelerates the deployment of virtually any type of remote patient monitoring application for healthcare and clinical trials. They leverage physiology-optimized medical wearable sensors and related data services to enable a deeper and more clinical understanding between provider and patient. Examples of Remote Patient Monitoring applications include cardiac arrhythmia, cryptogenic stroke, cardiac rehab, COPD, neutropenia, and cytokine release syndrome.
Vivalink Medical’s technology has been installed in 45 countries worldwide, granted 20 patents, and utilized in 21 research institutions. The company is collaborating with 250+ commercial partners.
FinSMEs
10/11/2023